Catalyst Wire Dossier Catalyst Wire Dossier

Emadine

emedastine difumarate · Immedica Pharma AB
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Emadine, covering 2025-03-25 to 2025-03-25. Get the full timeline:

Most recent: EMA Authorised: Emadine (emedastine difumarate) — Immedica Pharma AB

See pricing